USS Investment Management’s DraftKings DKNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
109,692
+28,756
+36% +$709K 0.01% 477
2026
Q1
$1.75M Hold
80,936
– – 0.01% 486
2025
Q4
$2.79M Hold
80,936
– – 0.01% 457
2025
Q3
$3.03M Hold
80,936
– – 0.01% 453
2025
Q2
$3.47M Hold
80,936
– – 0.02% 425
2025
Q1
$2.69M Hold
80,936
– – 0.02% 457
2024
Q4
$3.01M Sell
80,936
-18,593
-19% -$738K 0.02% 474
2024
Q3
$3.9M Buy
+99,529
New +$3.6M 0.03% 435
2022
Q3
– Sell
-79,379
Closed -$927K – 622
2022
Q2
$927K Hold
79,379
– – 0.01% 615
2022
Q1
$1.54M Buy
79,379
+40,450
+104% +$859K 0.01% 598
2021
Q4
$1.07M Hold
38,929
– – 0.01% 681
2021
Q3
$1.88M Buy
38,929
+774
+2% +$41K 0.02% 636
2021
Q2
$1.99M Hold
38,155
– – 0.02% 427
2021
Q1
$2.34M Buy
38,155
+1,316
+4% +$79K 0.02% 375
2020
Q4
$1.72M Buy
+36,839
New +$1.75M 0.02% 411

Other funds holding DKNG

USS Investment Management's DKNG Position: Q2 2026 in Review

USS Investment Management increased its DraftKings (DKNG) stake by 36% in Q2 2026, buying an estimated $709K and bringing the position to 109,692 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #477.

USS Investment Management first reported a position in DKNG in Q4 2020 and has held it in 15 quarters since. The position peaked at $3.9M in Q3 2024. 694 funds tracked by Wall St. Rank hold DKNG as of Q2 2026.

  • USS Investment Management held 109,692 shares of DraftKings worth $2.77M as of Q2 2026.
  • USS Investment Management bought 28,756 DraftKings shares in Q2 2026, an estimated $709K.
  • DraftKings made up 0.01% of USS Investment Management's portfolio in Q2 2026, its #477 holding.
  • USS Investment Management first reported a position in DraftKings in Q4 2020 and has held it in 15 quarters since.
  • USS Investment Management's DraftKings position peaked at $3.9M in Q3 2024.
  • 694 funds tracked by Wall St. Rank held DraftKings as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.